This Simple, Lifesaving Liquid Is Suddenly in Short Supply

Small saline-solution bags are ubiquitous in modern hospitals, cost about $1.50 each, and are the preferred method for delivering everything from painkillers and antibiotics to chemotherapy and heart drugs. The Cleveland Clinic, a top academic medical center, uses the bags to administer 350 different medicines, typical for hospitals across the country.

But supplies are running dangerously low. A long-standing problem, the situation worsened when Hurricane Maria slammed into Puerto Rico, knocking out power at factories that make the small bags for Baxter International Inc., the product's biggest supplier. Another large maker of the bags, B. Braun Medical Inc., is having problems of its own-the U.S. Food and Drug Administration is looking into reports of leaky and moldy intravenous bags. And a third, ICU Medical Inc., hasn't been able to keep up with the increased demand. The industry has also been swept up in a U.S. Department of Justice criminal probe of possible collusion and price-fixing.

"What else is going to run out?" says Scott Knoer, Cleveland Clinic's chief pharmacy officer. "I'm just scared of what's next." Hospital staffs across the country are living the same nightmare. "I find it shocking that in the richest country in the world we run out of fundamental, basic supplies," says Martha Kuhl, an oncology nurse at UCSF Benioff Children's Hospital Oakland.

It's a crisis that's been years in the making. Lacking the appeal of the latest $100,000 wonder drug, basic hospital supplies with thin profit margins are low priorities for a consolidating pharma industry that has failed to modernize outmoded factories or ramp up supply. In August, Braun Medical instructed customers to seek alternatives in the wake of what it called " unplanned production interruptions " at its IV-solutions factories.

That was three months after the FDA slapped the company with a warning letter for "repeat violations" after it failed to correct quality problems resulting in leaky and contaminated intravenous bags at its Irvine, Calif., plant. Braun didn't respond to requests for comment, but in a letter posted on the FDA website it promised improvements "in the coming weeks and months." Baxter says power has been restored at all but one of its Puerto Rico plants.

The FDA says it's working to alleviate shortages, allowing temporary imports and speeding up reviews for drugmakers seeking to make IV fluids, according to Valerie Jensen, an associate director at the FDA's Center for Drug Evaluation and Research. That may not be enough. The shortages put the system "on the brink of a significant public health crisis," the American Hospital Association warned in a Nov. 9 letter to Congress .

A bigger shadow looms over the industry. The Justice Department has launched a criminal investigation into the business practices of saline bag producers. In April, following an earlier class action alleging price-fixing, Baxter disclosed it was subpoenaed in an ongoing government probe into shortages of intravenous solutions, including saline. The investigation follows a 2015 letter from a group of U.S. senators citing reports that prices had tripled during earlier saline shortages and calling for the Federal Trade Commission to look into possible price-fixing among Baxter, Braun, and Hospira Infusion Systems- Pfizer Inc.'s former saline and IV-fluids unit, now owned by ICU Medical. Baxter says it's cooperating with the Justice Department probe.

ICU Medical says it believes the investigation focuses on a time frame prior to its ownership of the business. Pfizer says it's coordinating with ICU Medical to produce records for the Justice Department.

It's not just saline bags that are in short supply. Inventories are running low on 174 drugs, according to Erin Fox, director of the drug information service at University of Utah Health. That leaves little margin for error when an unforeseen event, like a hurricane, throws production into disarray. Other scarce hospital staples include syringes of sodium bicarbonate -the ingredient in baking soda-used for heart attack patients, and certain injected forms of morphine.

Pfizer's Hospira unit, which makes both types of products, has been plagued by factory quality-control problems for years, leading to shortages of various drugs. The factories "are taking a little bit longer to remediate than we thought," Pfizer Chief Financial Officer Frank D'Amelio said on a recent conference call with analysts, promising to fix most of the issues by the end of 2018. As a result of the problems, Pfizer's sales of injected hospital drugs declined 12 percent in the third quarter.

Finding alternatives to injectables isn't easy. While some drugs can be taken orally and others administered through a syringe, it's expensive and time-consuming to change hospitals' operating procedures. The more a workflow is changed, the greater the chances of medication errors, nurses and pharmacists say.

UW Health, the hospital system affiliated with the University of Wisconsin at Madison, is spending $1 million on alternatives to Baxter's saline bags, including renting hundreds of drug pumps that can deliver medicines via syringe and buying other drugs in premixed bags, says Philip Trapskin, UW's program director for medication use strategy.

Injected drugs are harder to produce than pills because they must be made under sterile conditions. They account for 72 percent of the country's drug shortages, according to a January report from Pew Charitable Trusts and the International Society for Pharmaceutical Engineering. The report cited factory quality-control problems and companies withdrawing from the market.

"I can't believe that one plant in only one place makes so much of a critical product that every hospital needs to function," says Fox of University of Utah Health, referring to Baxter's hurricane-hit operations. "We have all hands on deck every day. It's a logistics nightmare."

Read This Simple, Lifesaving Liquid Is Suddenly in Short Supply on


More Related News

Prosecutors urge charging New York policeman in 2014 choke hold death: NY Times
Prosecutors urge charging New York policeman in 2014 choke hold death: NY Times
  • US
  • 2018-04-20 17:21:45Z

Federal civil rights prosecutors have recommended charging a white New York City police officer for putting Eric Garner, an unarmed black man, in a fatal choke hold during a 2014 arrest, the New York Times reported on Friday, citing unnamed officials. Garner, a 43-year-old father of six, was stopped by police on July 17, 2014, for illegally peddling cigarettes on a sidewalk in New York's Staten Island borough. Garner argued with police and was tackled by Pantaleo, who brought Garner to the ground with an arm around his neck.

Ex-FBI No. 2 alerted then-FBI chief Comey of plans to talk to press: lawyer
Ex-FBI No. 2 alerted then-FBI chief Comey of plans to talk to press: lawyer
  • US
  • 2018-04-20 16:04:39Z

By Sarah N. Lynch WASHINGTON (Reuters) - Former FBI Deputy Director Andrew McCabe sent emails to then-Director James Comey alerting him he planned to push back against negative news coverage related to his oversight of probes into former Secretary of State Hillary Clinton, a lawyer for McCabe said on Friday. In an interview with reporters, Michael Bromwich said the emails could help clear McCabe of allegations by the Justice Department's internal watchdog that McCabe "lacked candor" with Comey by misleading him into thinking McCabe did not authorize disclosures to a newspaper to combat articles about his wife's political campaign and his role in overseeing an investigation into the...

Comey memo: Trump complained about Flynn
Comey memo: Trump complained about Flynn's 'judgment issues'

President Donald Trump told former FBI Director James Comey that he had serious concerns about the judgment of his first national security adviser, Michael Flynn, and Trump's chief of staff asked days later if Flynn's communications were being monitored under a secret surveillance warrant, according

Puerto Rico hit by island-wide power blackout
Puerto Rico hit by island-wide power blackout
  • US
  • 2018-04-18 19:48:38Z

A power line failure in southern Puerto Rico cut electricity to almost all 3.4 million residents on Wednesday, the latest in a string of operational and political headaches for the U.S. territory's bankrupt, storm-ravaged power utility. In a statement, the Puerto Rican Electric Power Authority, known as PREPA, said "technical personnel" were working to determine a cause and expected to restore service in 24 to 36 hours. Puerto Rico's smaller islands of Culebra and Vieques, as well as a pair of microgrids on the main island, were unaffected.

Puerto Rico is experiencing an island-wide blackout
Puerto Rico is experiencing an island-wide blackout

Seven months after Hurricane Maria devastated the island of Puerto Rico, the

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Economy

Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.